Trademark: 97673825
Status Date
Tuesday, December 5, 2023
Filing Date
Friday, November 11, 2022
Published for Opposition
Tuesday, October 10, 2023
5 Pharmaceutical preparations for human use for schizophrenia, adjunctive treatment of schizophrenia, schizoaffective disorder, bipolar disorder, bipolar mania, DiGeorge syndrome, Lesch-Nyhan syndrome, and movement disorders, namely, Myoclonus, chorea associated with Huntington's Disease, Levodopa-induced dyskinesia, dyskinetic cerebral palsy, dystonia, and tics
The mark consists of a sequence of right pointing arrows colored pink on the left shading into orange outlined with white lines and the word "INGREZZA" in black. The other white in the mark is background and is not claimed as a feature.
The color(s) pink, orange, white, and black is/are claimed as a feature of the mark.
Apr 19, 2023
Teas Change Of Owner Address Received
Nov 15, 2022
New Application Entered
Dec 3, 2022
New Application Office Supplied Data Entered
Dec 6, 2022
Notice Of Design Search Code E-Mailed
Apr 19, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 19, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 19, 2023
Teas Change Of Correspondence Received
Apr 19, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 25, 2023
Assigned To Examiner
Sep 5, 2023
Approved For Pub - Principal Register
Sep 20, 2023
Notification Of Notice Of Publication E-Mailed
Oct 10, 2023
Published For Opposition
Oct 10, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 5, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 12, 2024
Sou Teas Extension Received
Apr 12, 2024
Teas Request To Divide Received
Apr 12, 2024
Teas Statement Of Use Received
Apr 23, 2024
Case Assigned To Intent To Use Paralegal
Trademark Alertz updated from USPTO on 2030-01-24
